The Positron Emission Tomography Department has extensive resources which include hot cells to manufacture radiopharmaceuticals for PET imaging. We currently synthesize several PET radiopharmaceuticals used in intramural clinical research protocols under IND or Radioactive Drug Research Committee authorization. A PET cGMP facility under construction will manufacture PET research radiopharmaceuticals for human use in compliance with recent FDA regulations.

Peter Herscovitch, M.D.
PHerscovitch@cc.nih.gov
301.451.4248

http://clinicalcenter.nih.gov/
pet/index.html